⚖️ The memorandum of understanding announced between the
@SECGov and the
@FDA formalizes a channel of cooperation that has long existed informally and inconsistently.
Clinical and regulatory developments have always been among the most powerful drivers of value, yet the agencies responsible for overseeing each side of that relationship have operated with limited structured visibility into one another's work.
An arrangement of this kind should allow both to bring their respective expertise to bear on situations that neither can fully evaluate alone.
At the DSA, we expect the practical effects to become visible in enforcement priorities and examination focus well before they appear in formal rulemaking.